China Resources Biological is a comprehensive pharmaceutical service provider, whose business covers the production, distribution and retail of pharmaceuticals and healthcare products. Therapeutic fields such as injection, pediatrics, respiratory system, etc. It owns a number of pharmaceutical brands including Sanjiu, Dong’e Ejiao, Shuanghe, Jiangzhong, Zizhu, etc. It also owns a number of retail pharmacies including China Resources Tang, Medicare New, Li’an Chain and Tongde Hall, etc. China Resources Biotech recently completed a B-round financing of 600 million yuan, led by the State Research Fund, followed by mixed reform funds, CCB Equity, Yueke Fund, and Wuxi Guolian. This round of financing will be mainly used to accelerate the research of innovative biological drugs, promote the R&D pipeline in the clinical trial stage, and introduce external projects.
This article is transferred from: https://www.itjuzi.com/investevent/13767079
This site is only for collection, and the copyright belongs to the original author.